Cancer biomarkers have transformed current practices in the oncology clinic. Continued
discovery and validation are crucial for improving early diagnosis, risk stratification, and …

In the last few decades, the epithelial cell adhesion molecule (EpCAM) has received
increased attention as the main membrane marker used in many enrichment technologies to …

Circulating rare cells in the blood are of great significance for both materials research and
clinical applications. For example, circulating tumor cells (CTCs) have been demonstrated …

Metastases and cancer recurrence are the main causes of cancer death. Circulating Tumor
Cells (CTCs) and disseminated tumor cells are the drivers of cancer cell dissemination. The …

Circulating tumour cells (CTCs) have recently been identified as valuable biomarkers for
diagnostic and prognostic evaluations, as well for monitoring therapeutic responses to …

Isolation of circulating tumor cells (CTCs) from blood samples has important prognostic and
therapeutic implications for cancer treatments, but the process is very challenging due to the …

Oral cancer, a universal malady, has become a stumbling block over the years due to its
significant morbidity and mortality rates. The greater morbidity associated with this deadly …

With high level of morbidity and mortality, tumor is one of the deadliest diseases worldwide.
Aiming to tackle tumor, researchers have developed a lot of strategies. Among these …

Isolation and analysis of circulating tumor cells (CTCs) from peripheral blood provides a
potential way to detect and characterize cancer. Existing technologies to separate or capture …

Negative selection-based circulating tumor cell (CTC) isolation is able to harvest viable,
label-free, and clinically meaningful CTCs from the cancer patients' blood. Nevertheless, its …